author-photo

E. G. Hanania

University of Texas MD Anderson Cancer Center

25

Papers

1285

Citations

Citation Trend

Filter By

Papers (25) Sort By

Journal Conference Others

Transplantation Hematopoietic Cells: A Potential Purging Method for Autologous Reduce Breast Cancer Cells 1 Million-Fold When They Contaminate Cytosine Deaminase Adenoviral Vector and 5-Fluorocytosine Selectively

2013
Show All
- Source
- Cite
- Save
Citations (0)
Transplantation with selected autologous peripheral blood CD34+Thy1+ hematopoietic stem cells (HSCs) in multiple myeloma: Impact of HSC dose on engraftment, safety, and immune reconstitution

2000 Experimental Hematology
Show All
- Source
- Cite
- Save
Citations (102)
Addition of the Human Interferon β Scaffold Attachment Region to Retroviral Vector Backbones Increases the Level of in Vivo Transgene Expression among Progeny of Engrafted Human Hematopoietic Stem Cells

2000 Human Gene Therapy
Show All
- Source
- Cite
- Save
Citations (32)
Real-time t(11;14) and t(14;18) PCR assays provide sensitive and quantitative assessments of minimal residual disease (MRD).

1999 Leukemia
Show All
- Source
- Cite
- Save
Citations (54)
Improved Quantitation of Minimal Residual Disease in Multiple Myeloma Using Real-Time Polymerase Chain Reaction and Plasmid-DNA Complementarity Determining Region III Standards

1998 Cancer Research
Show All
- Source
- Cite
- Save
Citations (123)
Chemotherapy immediately following autologous stem-cell transplantation in patients with advanced breast cancer.

1998 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (34)
Cytosine deaminase adenoviral vector and 5-fluorocytosine selectively reduce breast cancer cells 1 million-fold when they contaminate hematopoietic cells: A potential purging method for autologous transplantation

1998 Blood
Show All
- Source
- Cite
- Save
Citations (37)
Simultaneous Genetic Chemoprotection of Normal Marrow Cells and Genetic Chemosensitization of Breast Cancer Cells in a Mouse Cancer Gene Therapy Model

1997 Clinical Cancer Research
- E. G. Hanania
- Albert B. Deisseroth
Show All
- Source
- Cite
- Save
Citations (11)
Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy (Proceedings of the National Academy of Sciences (December 24, 1996) 93 (15346-15351))

1997 Proceedings of the National Academy of Sciences of the United States of America
Show All
- Source
- Cite
- Save
Citations (6)
Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy

1996 Proceedings of the National Academy of Sciences of the United States of America
Show All
- Source
- Cite
- Save
Citations (157)